Results 131 to 140 of about 978,532 (309)
Portuguese Health System – Challenges in Times of Genomics
Review of European and Comparative LawThis article presents the Portuguese health care system that combines the National Health Service, health subsystems and private health insurance. Genomic medicine is expanding the scope of its activity, and its main challenges in pre-natal medicine and
André Gonçalo Dias Pereira
doaj +1 more source
Effects of private health insurance on healthcare services during the MERS Pandemic: Evidence from Korea. [PDF]
Heliyon, 2023 Lee J.
europepmc +1 more source
Obamacare to Come: Seven Bad Ideas for Health Care Reform [PDF]
, 2009 President Obama has made it clear that reforming the American health care system will be one of his top priorities. In response, congressional leaders have promised to introduce legislation by this summer, and they hope for an initial vote in the Senate ...
Michael D. Tanner
core
British Journal of Clinical Pharmacology, EarlyView.Small and mid‐sized pharmaceutical innovators often have limited in‐house health economics and market access expertise, and may struggle to align development strategies of investigational medicinal products with health system needs and payer expectations.
Zoltán Kaló +5 more
wiley +1 more source
The Labor Market Effects of National Health Insurance : Evidence From Taiwan [PDF]
This paper investigates the impacts of national health insurance on the labor market, by considering the case of Taiwan, which implemented national health insurance in March 1995.
Kamhon Kan, Yen-Ling Lin
core
Low‐intervention clinical trials in Spain: Do they progress?
British Journal of Clinical Pharmacology, EarlyView.Abstract Aims Low‐Intervention Clinical Trials (LICTs) are generally pragmatic trials that investigate medicinal products already authorized for use. In 2014, simplified regulatory frameworks were introduced for LICTs with the aim of reducing regulatory burden and operational complexity, to foster non‐commercial clinical trials (NCCTs); the mandatory ...
Claudia Erika Delgado‐Espinoza +4 more
wiley +1 more source
ClinicoEconomics and Outcomes Research, 2013 Isaac AO Odeyemi,1 John Nixon21Senior Director and Head of Health Economics and Outcomes Research, Astellas Pharma UK Ltd, Chertsey, UK; 2Teaching Associate in Health Economics, Department of Economics and Related Studies, University of York, York ...
Odeyemi IA, Nixon J
doaj
Do patients need additional coverage for chronic ailments? Insights from hospital data
Journal of Education and Health PromotionBACKGROUND: Eliminating financial barriers and improving healthcare accessibility pertain to be key elements of the United Nation’s sustainable development goals.
Aswin Sugunan +3 more
doaj +1 more source
Cannabinoids and drug–drug pharmacokinetic interactions: Deciphering the risks
British Journal of Clinical Pharmacology, EarlyView.The relationship between cannabinoids and mental health has become a major focus of scientific inquiry and public discourse. Cannabinoids are diverse chemical compounds from the Cannabis species that have been explored for their therapeutic applications in treating chronic pain, psychiatric and neurological conditions, such as depression, schizophrenia,
Paraskevi Papakyriakopoulou +2 more
wiley +1 more source
After a Parent Left Employment, One in Five Children Lost Private Insurance [PDF]
, 2016 This brief focuses on children’s loss of private health insurance after a parent left his or her job voluntarily or involuntarily between May 2008 and the end of 2012. Author Kristin Smith reports that more than one in four privately insured children had
Smith, Kristin
core +1 more source